메뉴 건너뛰기




Volumn 55, Issue 12, 2016, Pages 3882-3902

Capturing Biological Activity in Natural Product Fragments by Chemical Synthesis

Author keywords

drug discovery; medicinal chemistry; natural products; organic chemistry; organic synthesis

Indexed keywords

BIOACTIVITY;

EID: 84960444581     PISSN: 14337851     EISSN: 15213773     Source Type: Journal    
DOI: 10.1002/anie.201505863     Document Type: Review
Times cited : (134)

References (288)
  • 7
    • 79953881471 scopus 로고    scopus 로고
    • Angew. Chem. 2010, 122, 9786-9823;
    • (2010) Angew. Chem. , vol.122 , pp. 9786-9823
  • 19
    • 84892881928 scopus 로고    scopus 로고
    • (Eds.: G. M. Cragg, D. G. I. Kingston, D. J. Newman), CRC, Taylor & Francis, Boca Raton, .
    • M. J. Yu, Y. Kishi, B. A. Littlefield, in Anticancer Agents from Natural Products (Eds.:, G. M. Cragg, D. G. I. Kingston, D. J. Newman,), CRC, Taylor & Francis, Boca Raton, 2012, pp. 317-345.
    • (2012) Anticancer Agents from Natural Products , pp. 317-345
    • Yu, M.J.1    Kishi, Y.2    Littlefield, B.A.3
  • 23
    • 85026960197 scopus 로고    scopus 로고
    • T/C=size of treated tumor/size of control tumor
    • T/C=size of treated tumor/size of control tumor.
  • 60
    • 84960398808 scopus 로고    scopus 로고
    • FDA approves new treatment option for late-stage breast cancer, press release, U.S. Food and Drug Administration last accessed: October 12, 2015
    • FDA approves new treatment option for late-stage breast cancer, press release, U.S. Food and Drug Administration, 2010; available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm233863.htm, last accessed: October 12, 2015;
    • (2010)
  • 81
    • 84903727936 scopus 로고    scopus 로고
    • additional studies also found that the migrastatin macroketone analogue also significantly increase the immobile fraction E-cadherin in vivo by FRAP (fluorescence recovery after photobleaching) in 2014 by Murphy and co-workers; see.
    • additional studies also found that the migrastatin macroketone analogue also significantly increase the immobile fraction E-cadherin in vivo by FRAP (fluorescence recovery after photobleaching) in 2014 by Murphy and co-workers; see, D. Lo Re, Y. Zhou, M. Nobis, K. I. Anderson, P. V. Murphy, ChemBioChem 2014, 15, 1459-1464.
    • (2014) ChemBioChem , vol.15 , pp. 1459-1464
    • Lo Re, D.1    Zhou, Y.2    Nobis, M.3    Anderson, K.I.4    Murphy, P.V.5
  • 87
    • 79953888040 scopus 로고    scopus 로고
    • Angew. Chem. 2007, 119, 8862-8865.
    • (2007) Angew. Chem. , vol.119 , pp. 8862-8865
  • 98
    • 16244389244 scopus 로고    scopus 로고
    • Angew. Chem. 2004, 116, 4441-4445.
    • (2004) Angew. Chem. , vol.116 , pp. 4441-4445
  • 125
    • 0000771495 scopus 로고
    • Angew. Chem. 1995, 107, 1883-1885;
    • (1995) Angew. Chem. , vol.107 , pp. 1883-1885
  • 144
    • 0009649947 scopus 로고
    • Angew. Chem. 1994, 106, 2578-2580;
    • (1994) Angew. Chem. , vol.106 , pp. 2578-2580
  • 163
    • 84960337134 scopus 로고    scopus 로고
    • [last accessed: May 2015 ]
    • for current clinical information, see http://clinicaltrials.gov [last accessed: May 2015 ].
  • 171
    • 0000663202 scopus 로고    scopus 로고
    • Angew. Chem. 1998, 110, 2526-2530;
    • (1998) Angew. Chem. , vol.110 , pp. 2526-2530
  • 174
    • 0042622985 scopus 로고    scopus 로고
    • Angew. Chem. 2000, 112, 2376-2379.
    • (2000) Angew. Chem. , vol.112 , pp. 2376-2379
  • 199
    • 78149419134 scopus 로고    scopus 로고
    • For a minireview on Prins macrocyclization approaches in polyketide natural product synthesis, see, E. A. Crane, K. A. Scheidt, Angew. Chem. Int. Ed. 2010, 49, 8316-8326;
    • (2010) Angew. Chem. Int. Ed. , vol.49 , pp. 8316-8326
    • Crane, E.A.1    Scheidt, K.A.2
  • 200
    • 80052607493 scopus 로고    scopus 로고
    • Angew. Chem. 2010, 122, 8494-8505.
    • (2010) Angew. Chem. , vol.122 , pp. 8494-8505
  • 204
    • 80051774232 scopus 로고    scopus 로고
    • Angew. Chem. 2010, 122, 4684-4688;
    • (2010) Angew. Chem. , vol.122 , pp. 4684-4688
  • 215
    • 84960462918 scopus 로고    scopus 로고
    • Angew. Chem. 2015, 127, 3179-3182.
    • (2015) Angew. Chem. , vol.127 , pp. 3179-3182
  • 219
    • 77956461217 scopus 로고    scopus 로고
    • Angew. Chem. 2005, 117, 1888-1890;
    • (2005) Angew. Chem. , vol.117 , pp. 1888-1890
  • 225
    • 0000004092 scopus 로고    scopus 로고
    • Angew. Chem. 1996, 108, 2991-2995;
    • (1996) Angew. Chem. , vol.108 , pp. 2991-2995
  • 235
    • 79960242078 scopus 로고    scopus 로고
    • Angew. Chem. 2011, 123, 4308-4312;
    • (2011) Angew. Chem. , vol.123 , pp. 4308-4312
  • 236
    • 80051679972 scopus 로고    scopus 로고
    • for a similar synthetic approach towards (+)-torrubiellone C, see.
    • for a similar synthetic approach towards (+)-torrubiellone C, see, H. J. Jessen, A. Schumacher, F. Schmid, A. Pfaltz, K. Gademann, Org. Lett. 2011, 13, 4368-4370.
    • (2011) Org. Lett. , vol.13 , pp. 4368-4370
    • Jessen, H.J.1    Schumacher, A.2    Schmid, F.3    Pfaltz, A.4    Gademann, K.5
  • 256
    • 84960442516 scopus 로고    scopus 로고
    • First Patient Enrolled in Phase IIb Clinical Trial of Rostafuroxin in Italy, press release last accessed: October 12
    • First Patient Enrolled in Phase IIb Clinical Trial of Rostafuroxin in Italy, press release, 2013, available from: http://www.leespharm.com/file/news/FOR%20IMMEDIATE%20RELEASE-Rostafuroxin%20first%20patient.pdf, last accessed: October 12, 2015.
    • (2013)
  • 259
    • 56749145904 scopus 로고    scopus 로고
    • Angew. Chem. 2008, 120, 7232-7235;
    • (2008) Angew. Chem. , vol.120 , pp. 7232-7235
  • 272
    • 84905368754 scopus 로고    scopus 로고
    • Angew. Chem. 2014, 126, 3872-3904;
    • (2014) Angew. Chem. , vol.126 , pp. 3872-3904
  • 282
    • 84866394025 scopus 로고    scopus 로고
    • Angew. Chem. 2011, 123, 10990-11018;
    • (2011) Angew. Chem. , vol.123 , pp. 10990-11018


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.